As well as XIAP, which is also involved in the recruitment of the TAK1 complex to the NF-κB signalosome, c-IAP1/2 proteins have been found to be highly expressed in a subset of human cancers, where they can promote NF-κB activation and cancer therapy resistance. The gene discussed is BIRC2; the disease is cancer.